Immunotherapy: A New Approach to Treating Multiple Myeloma with Daratumumab and Elotuzumab.
about
Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review.The Challenges of Daratumumab in Transfusion Medicine.Comparison of two dose levels of cyclophosphamide for successful stem cell mobilization in myeloma patients.Transfusion management for patients taking an anti-CD38 monoclonal antibody.Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma
P2860
Immunotherapy: A New Approach to Treating Multiple Myeloma with Daratumumab and Elotuzumab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immunotherapy: A New Approach ...... th Daratumumab and Elotuzumab.
@en
type
label
Immunotherapy: A New Approach ...... th Daratumumab and Elotuzumab.
@en
prefLabel
Immunotherapy: A New Approach ...... th Daratumumab and Elotuzumab.
@en
P2093
P2860
P356
P1476
Immunotherapy: A New Approach ...... th Daratumumab and Elotuzumab.
@en
P2093
Alexander Lesokhin
Angela Michael
Salma Afifi
P2860
P304
P356
10.1177/1060028016642786
P407
P577
2016-04-15T00:00:00Z